Clinical trial
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel - Sponsor's Protocol
NCT07221097 is registered in ClinicalTrials.gov with BioFire Defense LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel - Sponsor's Protocol
- Lead sponsor
- BioFire Defense LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 29, 2025
- Completion date
- April 30, 2026
- Enrollment
- 2,091 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus, covid, respiratory infection